Lv41
628 积分 2023-09-04 加入
A genome-wide siRNA screen identifies previously unknown proviral and antiviral host factors in HBV infection
1个月前
已完结
The Chronic Hepatitis B and Metabolic Dysfunction-Associated Steatotic Liver Disease Paradox: Friend or Foe?
1个月前
已完结
The selenium paradox friend or foe in breast cancer?
1个月前
已关闭
Hepatitis B
1个月前
已完结
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection
1个月前
已完结
ALG ‐020572, an Antisense Oligonucleotide for the Treatment of Chronic Hepatitis B Virus Infection Discontinued for Drug‐Induced Liver Injury
2个月前
已完结
OS-030 Efficacy and safety of xalnesiran with and without an immunomodulator in virologically suppressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label platform study (PIRANGA)
2个月前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
2个月前
已完结
Mechanism of action and treatment of type I interferon in hepatocellular carcinoma
3个月前
已完结
Discovery of hepatitis B virus subviral particle biogenesis inhibitors from a bioactive compound library
3个月前
已完结